GLP-1 receptor agonists — including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — have produced some of the most dramatic weight loss outcomes in the history of pharmacology. For millions of patients, that is life-changing. But significant, rapid weight loss comes with a cosmetic consequence that many patients discover only after the scale has moved: loose, lax skin and hollowed facial features that can make people look older and more tired even as their health has significantly improved.
"Ozempic face" — the colloquial term for the facial volume loss and hollowing that often accompanies GLP-1-driven weight loss — is one of the most common concerns new patients bring to Evolve Med Spa. And it doesn't stop at the face. Patients are also dealing with loose skin on the neck, arms, abdomen, thighs, and buttocks — areas collectively described as "Ozempic body." The good news: these changes are highly treatable with the right combination of dermal fillers, biostimulators, and energy-based skin tightening. Here's what actually works.
GLP-1 medications are remarkably effective. Clinical trials have demonstrated average weight loss of 15–20% of total body weight with semaglutide — results previously achievable only with bariatric surgery. But rapid, significant weight loss reduces the subcutaneous fat that gives skin its structural support. When fat loss outpaces the skin's ability to contract and remodel, laxity results.
The face is particularly vulnerable because facial fat loss is often disproportionate. Patients lose fat in the cheeks, temples, and jawline faster than the skin can adapt, creating a gaunt or hollow appearance even when their body weight and overall health have improved significantly. On the body, the abdomen, inner arms, inner thighs, and buttocks are the most commonly affected areas — skin that stretches during weight gain, or that has already lost elasticity with age, often cannot fully contract after rapid fat loss.
Facial concerns after GLP-1 weight loss typically fall into two categories: volume loss and skin quality. The most effective approach combines both.
For patients whose primary concern is hollowing in the cheeks, temples, or under-eye area, hyaluronic acid fillers can restore immediate volume. Volumizing formulas like Juvederm Voluma and Restylane Lyft are placed at the structural level to rebuild midface support and lift the overlying skin. Under-eye hollowing is addressed with softer, lower-viscosity fillers (Restylane-L, Belotero Balance) placed at the tear trough.
Most patients experiencing meaningful Ozempic-related facial wasting require more product than a standard anti-aging treatment — 4–8 syringes across multiple zones is typical for comprehensive facial restoration. Your provider will assess the specific pattern of your volume loss and map a treatment plan at consultation.
For more diffuse or significant facial volume loss, Sculptra (poly-L-lactic acid) is particularly well-suited. Rather than filling space directly, Sculptra stimulates your own collagen production — rebuilding the structural matrix beneath the skin over 2–3 months. This addresses both the volume deficit and the collagen loss that rapid fat change accelerates. Sculptra results last 2+ years, making it an efficient long-term investment for patients planning to maintain their GLP-1 results.
Morpheus8 is the workhorse treatment for GLP-1-related skin laxity. By delivering radiofrequency energy through microneedles into the deep dermis and subdermal tissue, Morpheus8 triggers a robust collagen remodeling response that physically tightens and firms loose skin. It is effective on the face, neck, jawline, and body — making it one of the few treatments that addresses both Ozempic face and Ozempic body in the same protocol. Three sessions spaced 4–6 weeks apart is the standard starting point.
For patients whose concern is surface texture, fine lines, and overall skin quality rather than structural laxity, SkinPen microneedling stimulates collagen production in the upper dermis through controlled micro-injuries. It improves skin texture, firmness, and tone over a series of sessions and pairs well with Morpheus8 as part of a comprehensive protocol.
For patients who prefer a fully biological approach, PRF (platelet-rich fibrin) provides both regenerative skin improvement and subtle volumization using growth factors derived from the patient's own blood. PRF is an excellent complement to fillers and energy-based treatments in a comprehensive GLP-1 recovery protocol — and for under-eye concerns specifically, PRF EZ Gel is an increasingly popular filler alternative.
Body laxity after GLP-1 weight loss requires a different toolkit from facial concerns. The most common areas patients seek treatment for:
The Morpheus8 body applicator delivers RF energy deeper than the facial protocol, making it well-suited for tightening loose skin on the abdomen, inner arms, and inner thighs. A series of three sessions spaced 4–6 weeks apart is standard, with results continuing to improve for 3–6 months after the final treatment as collagen remodeling continues.
For patients who have lost muscle mass alongside fat — a common side effect of GLP-1 medications, which do not spare lean mass during weight loss — Emsculpt uses high-intensity electromagnetic energy to stimulate supramaximal muscle contractions, rebuilding the muscular foundation that gives the body its shape. Building muscle also improves the appearance of overlying skin by providing the structural support that fat loss removed.
The "Ozempic butt" — loss of volume and projection in the gluteal area — has become one of the most common body complaints among GLP-1 patients. Sculptra, used off-label in the buttocks and hips, is one of the most effective ways to restore volume and shape without implants or surgery. For a detailed breakdown of how this works, see our guide to hip dip filler and non-surgical Sculptra butt lift.
Protocol and timing both matter. The general framework most providers follow:
For patients who are still actively losing weight, a consultation is still worthwhile — your provider can assess your current changes, identify what to start now vs. what to wait on, and build a staged treatment roadmap that sequences everything correctly.
Treatment for GLP-1-related skin changes is appropriate for patients who:
Patients who regain weight after stopping GLP-1 medications may see partial natural reversal of facial volume loss as fat pads refill. However, skin laxity and collagen loss typically do not self-correct and often benefit from treatment regardless of weight trajectory.
Some natural skin contraction occurs after weight loss, particularly in younger patients with good baseline skin elasticity. However, for patients over 35 or those who have lost more than 20–30 pounds, the skin's ability to self-contract is limited. Professional treatment produces meaningfully faster and more complete results than waiting — and some changes, particularly collagen loss, do not reverse on their own.
Generally yes — particularly for facial treatments. Energy-based treatments like Morpheus8 and microneedling can begin once your rate of weight loss has stabilized, even if you're still on medication. For comprehensive body contouring, most providers recommend waiting until weight has been stable for at least 3–6 months. A consultation will help you determine the right timing for your specific situation.
Most patients require three sessions spaced 4–6 weeks apart for optimal results. Patients with more significant laxity may benefit from a fourth session. Results continue to improve for 3–6 months after the final treatment as collagen remodeling continues.
No. Aesthetic treatments for GLP-1-related skin changes are considered cosmetic and are not covered by insurance. Evolve Med Spa offers financing options to make comprehensive treatment plans accessible — ask about CareCredit and Alle at your consultation.
It varies significantly by the degree of volume loss and how many areas are being addressed. A comprehensive facial protocol combining Sculptra and HA filler typically starts around $2,000–$4,000 for the initial series. Morpheus8 for skin tightening is typically $800–$1,200 per session. Your provider will give you a specific estimate at consultation based on your treatment plan.
────────────────────────────────────────────────────────────
The aesthetic side effects of GLP-1 weight loss are real — and they're very treatable when approached with the right protocol and timing. Our providers at Evolve Med Spa work with GLP-1 patients regularly and know how to sequence treatments for the best outcomes. Book your Ozempic skin consultation at Evolve Med Spa and we'll map a plan that matches where you are in your weight loss journey. offers financing options through CareCredit and Alle to make comprehensive treatment plans accessible.
